| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |